Core Scientific
CORZ

Core Scientific (CORZ) earnings history

Most recent quarter

Period end
Mar 31, 2026
EPS actual
−$1.06
EPS estimate
−$0.06
EPS surprise
−1574.57%
Revenue
$115.2M
Reported
May 6, 2026

The latest quarter in Core Scientific's table is Q1 2026, reported on May 6, 2026. The company posted a loss of $1.06 per share, far wider than the estimated loss of $0.06. Revenue was $115.2 million, 1.53% short of the $117.0 million consensus but 44.9% above the $79.5 million of Q1 2025. Q1 2025 had shown a profit of $1.25 per share.

Results have swung widely. The table holds eight quarters with gaps, as Q1 2024 and Q3 2025 are missing. Six of the eight quarters were losses, the deepest at $4.51 per share in Q2 2024. The two profitable quarters, Q1 2025 at $1.25 and Q4 2025 at $0.42, came against expected losses. Core Scientific beat the EPS estimate three times out of eight, and revenue topped the consensus only twice. Quarterly revenue ranged from $78.6 million in Q2 2025 to $141.9 million in Q4 2023.

Past second-quarter reports came on August 7, 2024 and August 8, 2025, but the table has no Q2 2026 row yet. The third quarter was reported on November 6, 2024, which points to early November 2026 for Q3. Those reports will show whether revenue stays near the Q1 2026 level.

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q1 2026May 6, 2026−$0.06−$1.06−1574.57%$115.2MSEC
Q4 2025Mar 2, 2026−$0.16$0.42+356.72%$79.8MSEC
Q2 2025Aug 8, 2025−$0.07−$0.04+44.37%$78.6MSEC
Q1 2025May 7, 2025−$0.12$1.25+1170.21%$79.5MSEC
Q4 2024Feb 26, 2025−$0.09−$0.60−574.16%$94.9MSEC
Q3 2024Nov 6, 2024−$0.09−$1.56−1570.06%$95.4MSEC
Q2 2024Aug 7, 2024$0.01−$4.51−53158.82%$141.1MSEC
Q4 2023Mar 12, 2024$0.07−$0.51−884.62%$141.9MSEC

Quarterly revenue

Q4 2023
$141.9M
Q2 2024
$141.1M
Q3 2024
$95.4M
Q4 2024
$94.9M
Q1 2025
$79.5M
Q2 2025
$78.6M
Q4 2025
$79.8M
Q1 2026
$115.2M

Frequently asked questions

  • When did Core Scientific (CORZ) last report earnings?

    Core Scientific last reported on May 6, 2026, covering fiscal Q1 2026.

  • Did CORZ beat earnings estimates?

    No. Core Scientific reported EPS of −$1.06 for Q1 2026 against a −$0.06 estimate — a 1574.57% miss.

  • How much revenue did CORZ report last quarter?

    Core Scientific reported $115.2M in revenue for Q1 2026, against a consensus estimate of $117.0M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.